AAAAAA

   
Results: 1-16 |
Results: 16
CLINDAMYCIN WITH PRIMAQUINE VS. TRIMETHOPRIM-SULFAMETHOXAZOLE THERAPYFOR MILD AND MODERATELY SEVERE PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITH AIDS - A MULTICENTER, DOUBLE-BLIND, RANDOMIZED TRIAL (CTN-004)
Authors: TOMA E THORNE A SINGER J RABOUD J LEMIEUX C TROTTIER S BERGERON MG TSOUKAS C FALUTZ J LALONDE R GAUDREAU C THERRIEN R
Citation: E. Toma et al., CLINDAMYCIN WITH PRIMAQUINE VS. TRIMETHOPRIM-SULFAMETHOXAZOLE THERAPYFOR MILD AND MODERATELY SEVERE PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITH AIDS - A MULTICENTER, DOUBLE-BLIND, RANDOMIZED TRIAL (CTN-004), Clinical infectious diseases, 27(3), 1998, pp. 524-530
ENGAGEMENT OF TCR CD3 INDUCES COLOCALIZATION OF EMT/ITK WITH THE CD3-EPSILON CHAIN/
Authors: CHING K KAWAKAMI Y KAWAKAMI T TSOUKAS C
Citation: K. Ching et al., ENGAGEMENT OF TCR CD3 INDUCES COLOCALIZATION OF EMT/ITK WITH THE CD3-EPSILON CHAIN/, Journal of leukocyte biology, 1998, pp. 143-143
CORRESPONDENCE BETWEEN THE EFFECT OF ZIDOVUDINE PLUS LAMIVUDINE ON PLASMA HIV LEVEL CD4 LYMPHOCYTE COUNT AND THE INCIDENCE OF CLINICAL-DISEASE IN INFECTED INDIVIDUALS
Authors: PHILLIPS AN ERON J BARTLETT J KURITZKES DR JOHNSON VA GILBERT C JOHNSON J KELLER A HILL AM AKIL B BEALL G BELLOS N BERRY P BRUMMIT C CAMERON B COHEN C DONABEDIAN H MAYAR K MCKINLEY G SEPULVEDA G THOMPSON M TSOUKAS C WALMSLEY S HORTON J KERKERING T MATTHEW E PEARCE D PETERSON D POTTAGE J SAMPSON J SMITH W YANGCO B COWAN J KACZKA C ZAMECK R DAWSON D POBINER B SCOTTLENNOX J DEMASI R JARRETT P YUEN G ESINHART J QUINN J FALLON MA BENOIT S
Citation: An. Phillips et al., CORRESPONDENCE BETWEEN THE EFFECT OF ZIDOVUDINE PLUS LAMIVUDINE ON PLASMA HIV LEVEL CD4 LYMPHOCYTE COUNT AND THE INCIDENCE OF CLINICAL-DISEASE IN INFECTED INDIVIDUALS, AIDS, 11(2), 1997, pp. 169-175
DRUG-SENSITIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES AFTER RIBAVIRIN THERAPY
Authors: BERNIER R TREMBLAY M TSOUKAS C BERGERON MG
Citation: R. Bernier et al., DRUG-SENSITIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES AFTER RIBAVIRIN THERAPY, The Journal of infectious diseases, 175(1), 1997, pp. 176-178
IMPACT OF MISSING DATA DUE TO DROPOUTS ON ESTIMATES OF THE TREATMENT EFFECT IN A RANDOMIZED TRIAL OF ANTIRETROVIRAL THERAPY FOR HIV-INFECTED INDIVIDUALS
Authors: RABOUD JM MONTANER JSG THORNE A SINGER J SCHECHTER MT RACHLIS A GILL J BEAULIEU R TSOUKAS C FANNING M CAMERON W LALONDE R BERGERON M SCHLECH W SALIT I PHILLIPS P SALOMON H SPIRA B CONWAY B AUCLAIR C CASSOL S OSHAUGHNESSY MV WAINBERG MA
Citation: Jm. Raboud et al., IMPACT OF MISSING DATA DUE TO DROPOUTS ON ESTIMATES OF THE TREATMENT EFFECT IN A RANDOMIZED TRIAL OF ANTIRETROVIRAL THERAPY FOR HIV-INFECTED INDIVIDUALS, Journal of acquired immune deficiency syndromes and human retrovirology, 12(1), 1996, pp. 46-55
HIV-1 RNA LEVELS AND THE DEVELOPMENT OF CLINICAL-DISEASE
Authors: PHILLIPS AN ERON JJ BARTLETT JA RUBIN M JOHNSON J PRICE S SELF P HILL AM AKIL B BEALL G BELLOS N BERRY P BRUMMIT C CAMERON B COHEN C DONABEDIAN H MAYAR K MCKINLEY G SEPULVEDA G THOMPSON M TSOUKAS C WALMSLEY S HORTON J KERKERING T MATTHEW E PEARCE D PETERSON D POTTAGE J SAMPSON J SMITH W YANGCO B COWAN J KACZKA C ZAMECK R DAWSON D POBINER B GILBERT C SCOTTLENNOX J DEMASI R JARRETT P YUEN G ESINHART J QUINN J FALLON MA BENOIT S
Citation: An. Phillips et al., HIV-1 RNA LEVELS AND THE DEVELOPMENT OF CLINICAL-DISEASE, AIDS, 10(8), 1996, pp. 859-865
PLASMA VIREMIA IS MORE PREDICTIVE OF DISEASE PROGRESSION THAN CD4 COUNTS IN HIV-INFECTED INDIVIDUALS WITH CD4 COUNTS GREATER-THAN 500 IN A RANDOMIZED TRIAL OF IMMUNIZATION WITH RGP160
Authors: JANET R TSOUKAS C BERNARD N DJURDJEV O CASSOL S CHERNOFF D FONG I FREEDMAN J GILL J GOLDBERG E LAFRENIERE R LEE S MONTANER J POON MC RACHLIS A SCHLECH W SMITH G SZABO J TODD J THOMAS R VOLVOVITZ F
Citation: R. Janet et al., PLASMA VIREMIA IS MORE PREDICTIVE OF DISEASE PROGRESSION THAN CD4 COUNTS IN HIV-INFECTED INDIVIDUALS WITH CD4 COUNTS GREATER-THAN 500 IN A RANDOMIZED TRIAL OF IMMUNIZATION WITH RGP160, AIDS, 10, 1996, pp. 63-63
COMPARISON OF ITRACONAZOLE AND KETOCONAZOLE IN HIV-POSITIVE PATIENTS WITH OROPHARYNGEAL OR ESOPHAGEAL CANDIDIASIS
Authors: DEREPENTIGNY L RATELLE J BARIL JG FRECHETTE G MONTCARMEL C TSOUKAS C LEMIEUX C VINCELETTE J LALONDE R RENE P PHANEUF D COTE P DASCAL A AUGER P CHOLETTE P STGERMAIN G
Citation: L. Derepentigny et al., COMPARISON OF ITRACONAZOLE AND KETOCONAZOLE IN HIV-POSITIVE PATIENTS WITH OROPHARYNGEAL OR ESOPHAGEAL CANDIDIASIS, Chemotherapy, 42(5), 1996, pp. 374-383
LAMIVUDINE PLUS ZIDOVUDINE COMPARED WITH ZALCITABINE PLUS ZIDOVUDINE IN PATIENTS WITH HIV-INFECTION
Authors: BARTLETT JA BENOIT SL JOHNSON VA QUINN JB SEPULVEDA GE EHMANN WC TSOUKAS C FALLON MA SELF PL RUBIN M
Citation: Ja. Bartlett et al., LAMIVUDINE PLUS ZIDOVUDINE COMPARED WITH ZALCITABINE PLUS ZIDOVUDINE IN PATIENTS WITH HIV-INFECTION, Annals of internal medicine, 125(3), 1996, pp. 161
ZIDOVUDINE PLUS INTERFERON-ALPHA VERSUS ZIDOVUDINE ALONE IN HIV-INFECTED SYMPTOMATIC OR ASYMPTOMATIC PERSONS WITH CD4-THAN-150X10(6)( CELL COUNTS GREATER)I - RESULTS OF THE ZIDON TRIAL/
Authors: FERNANDEZCRUZ E LANG JM FRISSEN J FURNER V CHATEAUVERT M BOUCHER CAB DOWD P STEVENS J GOLD J MICHELMORE H BENSON E SPELMAN E HOY J WRIGHT E FRENCH M HUDSON J MALLAL S BODSWORTH N STINGL G MAYERHOFER S KRONAWETTER M TSOUKAS C SZABO T KATLAMA C GUERMONPREZ G RAFFI F BILLAUD E MILPIED B BOURGEOT V FLEISHMANN M BARRIER JH DELZANT G WINTER C MEHARZI J TREPO C COTTE L ROUGIER P HASSAIRI N CHOUTET P BESNIER JM LAFEUILLADE A RASOKAT H GROSS G MAUSCH HE STRATIGOS J POLYDOROV D STAVRIANEAS N KIOSSES V MANDALAKI T KARAFOULIDOU A KARABINIS A STERGIOU G PLOUMIDES G PITSAS A TASSOPOULOS N KOUTSOUNOPOULOS G HATZAKIS A MORONI M DARMINIO A BINI T CHIODO F COLANGELI V RICCHI E AIUTI F FERRARA R MEZZAROMA I LANGE JMA FRISSEN PHJ SPRENGER HG KROON FP VANDERENDE ME DEMARIE S KOOPMANS PP DOLMANS WMV SCHREIJ GS WEIGEL HM TENNAPEL CHH TENKATE RW MARANON G ZABAY JM COSIN J PENA JM RUBIO R RIBERA E VAZQUEZ JMM LEAL M ANDREU J CARTON JA ASENSI V GOMEZTRUJILLO F ORIHUELA F SERRANO C FERRER E MANDAL BK JOHNSON M MCKARTHY K FARMER D TANG A MITCHELL SA BROWN J TOORAWA R YEO J
Citation: E. Fernandezcruz et al., ZIDOVUDINE PLUS INTERFERON-ALPHA VERSUS ZIDOVUDINE ALONE IN HIV-INFECTED SYMPTOMATIC OR ASYMPTOMATIC PERSONS WITH CD4-THAN-150X10(6)( CELL COUNTS GREATER)I - RESULTS OF THE ZIDON TRIAL/, AIDS, 9(9), 1995, pp. 1025-1035
DIDANOSINE COMPARED WITH CONTINUED ZIDOVUDINE THERAPY FOR HIV-INFECTED PATIENTS WITH 200 TO 500 CD4 CELLS MM(3) - A DOUBLE-BLIND, RANDOMIZED, CONTROLLED TRIAL/
Authors: MONTANER JSG SCHECHTER MT RACHLIS A GILL J BEAULIEU R TSOUKAS C RABOUD J CAMERON B SALOMON H DUNKLE L SMALDONE L WAINBERG MA FANNING M LALONDE R BERGERON M SCHLECH W SALIT I PHILLIPS P SPIRA B CONWAY B CASSOL S OSHAUGNESSY M THORNE A SINGER J AUCLAIR C
Citation: Jsg. Montaner et al., DIDANOSINE COMPARED WITH CONTINUED ZIDOVUDINE THERAPY FOR HIV-INFECTED PATIENTS WITH 200 TO 500 CD4 CELLS MM(3) - A DOUBLE-BLIND, RANDOMIZED, CONTROLLED TRIAL/, Annals of internal medicine, 123(8), 1995, pp. 561-571
CHARACTERIZATION OF AN IL-2 DEPENDENT HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I (HTLV-I) INFECTED CELL-LINE - A SYSTEM FOR STUDYING HTLV-I MEDIATED TRANSFORMATION
Authors: ROHWER F MACMASTER W HASELTINE WA TSOUKAS C MCGUIRE KL
Citation: F. Rohwer et al., CHARACTERIZATION OF AN IL-2 DEPENDENT HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I (HTLV-I) INFECTED CELL-LINE - A SYSTEM FOR STUDYING HTLV-I MEDIATED TRANSFORMATION, International journal of oncology, 5(5), 1994, pp. 1163-1169
ACCURATE AND DIFFERENTIAL QUANTITATION OF HIV-1 TAT, REV AND NEF MESSENGER-RNAS BY COMPETITIVE PCR
Authors: MERZOUKI A MO T VELLANI N PATTULLO A ESTABLE M OSHAUGHNESSY M TSOUKAS C CASSOL S
Citation: A. Merzouki et al., ACCURATE AND DIFFERENTIAL QUANTITATION OF HIV-1 TAT, REV AND NEF MESSENGER-RNAS BY COMPETITIVE PCR, Journal of virological methods, 50(1-3), 1994, pp. 115-128
EFFECT OF 3'-AZIDO-3'-DEOXYTHYMIDINE AND 2',3'-DIDEOXYINOSINE ON ESTABLISHMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION IN CULTUREDCD8(+) LYMPHOCYTES
Authors: MERCURE L BRENNER BJ PHANEUF D TSOUKAS C WAINBERG MA
Citation: L. Mercure et al., EFFECT OF 3'-AZIDO-3'-DEOXYTHYMIDINE AND 2',3'-DIDEOXYINOSINE ON ESTABLISHMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION IN CULTUREDCD8(+) LYMPHOCYTES, Antimicrobial agents and chemotherapy, 38(5), 1994, pp. 986-990
IMMUNOLIPOSOME TARGETING TO MURINE CD4(+) LEUKOCYTES IS DEPENDENT ON IMMUNE STATUS
Authors: PHILLIPS NC GAGNE L TSOUKAS C DAHMAN J
Citation: Nc. Phillips et al., IMMUNOLIPOSOME TARGETING TO MURINE CD4(+) LEUKOCYTES IS DEPENDENT ON IMMUNE STATUS, The Journal of immunology, 152(6), 1994, pp. 3168-3174
EFFECTS OF LOVASTATIN ON NATURAL-KILLER-CELL FUNCTION AND OTHER IMMUNOLOGICAL PARAMETERS IN MAN
Authors: MCPHERSON R TSOUKAS C BAINES MG VOST A MELINO MR ZUPKIS RV PROSS HF
Citation: R. Mcpherson et al., EFFECTS OF LOVASTATIN ON NATURAL-KILLER-CELL FUNCTION AND OTHER IMMUNOLOGICAL PARAMETERS IN MAN, Journal of clinical immunology, 13(6), 1993, pp. 439-444
Risultati: 1-16 |